Which type of training did you complete?

Live conferences

Overview

Join us for a SCOPE of Pain Live Meeting!

These three- to four-hour meetings will address the essential content outlined in the agenda, and often include state-specific policy and resource panels. These panels, modeled on our successful New England programming, consist of representatives from state and federal regulatory agencies — including, but not limited to, State Departments of Public Health (including the Prescription Drug Monitoring Program (PDMP) and addiction treatment services), regional Drug Enforcement Administration offices, State Licensing Boards, State Attorneys General and State Police. They bring information and resources to clinicians, and open a valuable dialogue between regulatory agencies and clinicians. The panel discussions have been invaluable and are intended to increase provider use of state programs and resources.

GET STARTED NOW! Select a conference

Course Director

Daniel P. Alford, MD, MPH, FACP, FASAM
Professor of Medicine
Assistant Dean, Continuing Medical Education, Boston University School of Medicine

Who is this for?

Physicians, nurse practitioners, physician assistants, registered nurses, nurses, dentists, pharmacists and allied healthcare professionals

Why do I need this education?

Chronic pain affects approximately 100 million in the US, making it one of the most common reasons for patients to seek medical care. Unfortunately, pain management, including the appropriate use of opioids, is not well covered in medical training. Moreover, there are inadequate numbers of pain management specialists to help generalist providers manage these patients.

Partly in response to the problem of under-treatment of pain, over the past decade there has been a four-fold increase in opioid prescribing. During the same time period there was a four-fold increase in unintentional opioid overdose deaths and a five-fold increase in substance abuse treatment admissions for prescription opioid addiction.

Providers who prescribe ER/LA opioid analgesics to treat chronic pain are in a key position to balance the benefits and risks of chronic opioid therapy (COT). However, providers struggle with the need to assist their patients with adequate management of chronic pain while confronting the risks associated with opioid prescribing. Our educational program looks to address that need. Strategies for multidisciplinary, inter-professional care are addressed in this curriculum.

Educational objectives

Accreditation

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center?s Commission on Accreditation.

These activities are sponsored by Boston University School of Medicine in collaboration with the Council of Medical Specialty Societies (CMSS) and the Federation of State Medical Boards (FSMB). Our program addresses many key elements of the physician education component of the Obama Administration's prescription drug abuse prevention plan on prescriber education released in April 2011.

Disclosure of support

This educational activity is supported by an independent educational grant from the Extended-Release/Long-Acting Opioid Analgesic REMS Program Companies. Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Extended-Release/Long-Acting Opioid Analgesics REMS education requirements issued by the US Food & Drug Administration.

Get Adobe Acrobat Reader DC.png

Accreditation

These activities were planned in collaboration with the Council of Medical Specialty Societies and the Federation of State Medical Boards.

Physicians

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

These activities have been approved for AMA PRA credit.

AMA PRA Category 1 Credits™: Varies with meeting: See meeting agenda for details

Nurses

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

CNE Contact Hours: Varies with meeting: See meeting agenda for details

Risk Management and Pain Management Credits

This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management and opioid education. Several states have similar requirements. Please check with your Board to determine if this activity will fulfill your state's specific requirements and be sure to check back here as we update and add approvals to these listed below.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for opioid education.

American Academy of Family Physicians

This Live activity, SCOPE of Pain: Safe & Competent Opioid Prescribing Education, from 11/14/2015-11/13/2016, has been reviewed and is acceptable for up to 2.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification Part 2 Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Needs addressed

Healthcare practitioners who prescribe ER/LA opioid analgesics to treat chronic pain are in a key position to balance the benefits and risks of Chronic Opioid Treatment (COT). The importance of education for HCPs cannot be overstated as, according to a 2011 report by the Institute of Medicine, the social and economic burden of pain nationwide is staggering. The IOM Report found that the annual health economic impact of pain represents a $560 to $635 billion burden to the U.S. The escalation of opioid prescribing and the corresponding increase in opioid misuse (including abuse, addiction, overdose, and diversion) have been well documented by both regulatory agencies and the lay press. According to SAMHSA's 2010 National Survey of Drug Use and Health report, among the U.S. population aged 12 or older, nonmedical use of prescription pain relievers was the second most prevalent type of illicit drug use after marijuana use. In addition, mortality rates from unintentional overdose of opioids are increasing dramatically. Despite these concerns, according to the National Institute on Drug Abuse, opioid pain medicines are safe and usually do not cause addiction when managed well medically and taken as prescribed. However, HCPs struggle with the need to assist their patients with adequate management of chronic pain while confronting the risks associated with opioid prescribing.

  1. Institute Of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington DC: The National Academies Press. 2011.
  2. Jamison RN, Clark D. Opioid Medication Management Clinician Beware! Anesthesiology 2010;112:777-8.
  3. Substance Abuse and Mental Health Services Administration. (2010). Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4856Findings). Rockville, MD.
  4. National Institute on Drug Abuse. "Research Report Series — Prescription Drugs: Abuse and Addiction." Available at: http://www.drugabuse.gov/ResearchReports/Prescription/prescription2.html. Accessed April 9, 2012.

Target audience

Physicians, nurse practitioners, registered nurses, nurses, physician assistants, dentists, and pharmacists

Educational objectives

At the conclusion of these activities, participants will be better able to:

For questions about CME, please contact cme@bu.edu or www.bu.edu/cme.

To view Boston University's privacy policy, please review: http://www.bumc.bu.edu/cme/policies/.

Disclosures

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve apparent conflicts of interest. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceuticals and devices occurs.

Off-Label Discussion

This activity does include discussion of the off-label use of sublingual buprenorphine to treat pain. Sublingual buprenorphine has been FDA approved for addiction treatment but not pain treatment. This presentation does include discussion of the off-label use of clonidine and tizanidine to treat opioid withdrawal symptoms. Clonidine and tizanidine are not FDA approved for this use.

Faculty

Daniel P. Alford, MD, MPH, FACP
Course Director

Associate Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support.

Seddon Savage, MD
Adjunct Associate Professor of Anesthesiology
Geisel School of Medicine
Dartmouth Medical School
Hanover, NH
Dr. Savage has nothing to disclose with regards to commercial support.

Additional Original Content Development
Lynn Webster, MD, FACPM, FASAM, CRI-Lifetree
Dr. Webster is a consultant for Covidien Mallinckrodt, Medtronic, Nektar Therapeutics, and Salix Pharmaceuticals.

Online Program Moderator
Judie Yuill
, Fill-in News Anchor and Host at WGBH Boston and Exclusive Female Voice at Parlance Corp
Ms. Judie Yuill has nothing to disclose with regard to commercial support.

Planning Committee
Ms. Patti-Ann Collins
, Lead Nurse Planner, Boston University School of Medicine CME Office
Ilana Hardesty, Program Operations Manager, Boston University School of Medicine CME Office
Ms. Colleen Labelle, CNE Course Advisor, Boston University School of Medicine CME Office
Stephen A. Wyatt, DO, and Jason Worcester, MD, independent reviewers
Planning Committee members have nothing to disclose with regard to commercial support.

Advisory Committee
Norman Kahn, MD
, Executive Vice-President and CEO, Council of Medical Specialty Societies
Stancel Riley, MD, Lecturer on Surgery, Harvard Medical School and Research Associate, Department of Health Policy Management, Harvard School of Public Health
Lisa Robin, Chief Advocacy Officer for the Federation of State Medical Boards
Advisory Committee members have nothing to disclose with regard to commercial support.

Disclaimer

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

Disclosure of support

This educational activity is supported by an independent educational grant from the Extended-Release/Long-Acting Opioid Analgesic REMS Program Companies. Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Extended-Release/Long-Acting Opioid Analgesics REMS education requirements issued by the US Food & Drug Administration.

Get Adobe Acrobat Reader DC.png

Agree
Boston University Council of Medical Specialty Societies Federation of State Medican Boards